Background-Digitalis-induced Na ϩ accumulation results in an increase in Ca 2ϩ i via the Na ϩ /Ca 2ϩ exchanger, leading to enhanced sarcoplasmic reticulum (SR) Ca 2ϩ load, responsible for the positive inotropic and toxic arrhythmogenic effects of glycosides. A digitalis-induced increase in Ca 2ϩ i could also activate calcium-calmodulin kinase II (CaMKII), which has been shown to have proarrhythmic effects. Here, we investigate whether CaMKII underlies digitalis-induced arrhythmias and the subcellular mechanisms involved. Methods and Results-In paced rat ventricular myocytes (0.5 Hz), 50 mol/L ouabain increased contraction amplitude by 160Ϯ5%. In the absence of electric stimulation, ouabain promoted spontaneous contractile activity and Ca 2ϩ waves. Ouabain activated CaMKII (p-CaMKII), which phosphorylated its downstream targets, phospholamban (PLN) (Thr17) and ryanodine receptor (RyR) (Ser2814). Ouabain-induced spontaneous activity was prevented by inhibiting CaMKII with 2.5 mol/L KN93 but not by 2.5 mol/L of the inactive analog, KN92. Similar results were obtained using the CaMKII inhibitor, autocamtide-2 related inhibitory peptide (AIP) (1 to 2.5 mol/L), and in myocytes from transgenic mice expressing SR-targeted AIP. Consistently, CaMKII overexpression exacerbated ouabain-induced spontaneous contractile activity.
C ardiotonic glycosides selectively bind to and inhibit the sarcolemmal Na ϩ /K ϩ -ATPase and cause an increase in intracellular Na ϩ , which in the heart reduces Ca 2ϩ extrusion and/or increases Ca 2ϩ influx through the Na ϩ /Ca 2ϩ exchanger (NCX). This increase in Ca 2ϩ i leads to an increase in sarcoplasmic reticulum (SR) Ca 2ϩ load and to a positive inotropic effect, which explains, at least in part, their thera-
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peutic use for heart failure treatment 1 ; however, these compounds have associated arrhythmic/toxic effects that conspire against their extensive use in the clinical practice. 2 The arrhythmic effects have been proposed to occur when the SR Ca 2ϩ storage capacity is exceeded so that oscillations of release-uptake cycles arise to re-establish the Ca 2ϩ equilibrium between the cytosol and the SR. These transient increases in Ca 2ϩ i (Ca 2ϩ waves) activate a transient inward (depolarizing) current (I ti ), primarily mediated by the forward-mode NCX current. This I ti is responsible for the generation of delayed after depolarizations (DADs), which, if sufficiently large, may achieve threshold and generate spontaneous action potentials, leading to extrasystoles and ventricular arrhythmias 3 ; however, several lines of evidence suggest that increased SR Ca 2ϩ load in itself is not sufficient to promote diastolic spontaneous SR Ca 2ϩ release. For example, phospholamban (PLN) knock-out mice, which have a fully loaded SR, have not proven to be prone to arrhythmias under basal conditions. 4, 5 Moreover, a recent report showed that ouabain-induced DADs could be prevented by using JTV-519, a putative RyR stabilizer, 6 suggesting that the underlying alteration responsible for ouabain-induced arrhythmias was at the level of the RyR rather than on the SR Ca 2ϩ load. Indeed, in addition to SR Ca 2ϩ overload, an increase in RyR open probability, resulting in enhanced SR Ca 2ϩ leak, is also a well-known substrate for triggering Ca 2ϩ waves, I ti , DADs, and, eventually, arrhythmias. 7 In a previous study, we showed that chronic treatment with low nontoxic doses of the cardiotonic steroid ouabain can induce apoptosis through a mechanism that requires CaMKII activation. 8 In this study, we found that the activation of the NCX during ouabain treatment leads to an increase in intracellular Ca 2ϩ i that results in CaMKII activation and culminates in apoptotic cell death. The above-mentioned signaling events could also be involved in cardiotonic steroid-induced arrhythmias, given that CaMKII activation has been shown to increase SR Ca 2ϩ load and leak and induce arrythmias 9 ; however, whether CaMKII contributes to glycoside-induced arrhythmias has not been previously assessed.
The aim of this study was to examine whether cardiotonic steroid-induced arrhythmias are CaMKII-dependent and, if so, to determine the underlying mechanisms involved. For this purpose, we assessed the spontaneous contractile activity associated with Ca 2ϩ waves as a proximal direct index of triggered DAD-like arrhythmias in rat myocytes, and we used transgenic mice as an experimental tool to assess the underlying mechanisms of cardiotonic steroid-triggered arrhythmias.
Methods

Myocyte Isolation and Culture
All experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals (NIH Publication No.85-23, revised 1996) and approved by the Institutional Animal Care and Use Committee of La Plata University. Wistar rats (200 to 300 g), BALB/c (wild-type [WT]), or transgenic mice with cardiomyocytedelimited transgenic expression of SR-targeted CaMKII inhibitor AIP (SR-AIP) or with a double-mutant nonphosphorylated form of phospholamban (PLN-DM), where the mutant PLN has alanine replacing both Ser-16 (PKA site) and Thr-17 (CaMKII site) (Mutant Mouse Regional Resource Center at the University of Missouri, Columbia, MO) were anesthetized by an intra-abdominal injection of sodium pentobarbitone (35 mg [Kg body weight] Ϫ1 ). Immediately after plane three of phase III of anesthesia was verified by the loss of the corneal reflex and the appearance of slow deep diaphragmatic breathing, central thoracotomy and heart excision were performed.
Myocytes were isolated by enzymatic digestion, as previously described. 10 Details can be found in the online-only Supplemental Material.
Indo-1 Fluorescence and Cell-Shortening Measurements
Isolated myocytes were loaded with indo-1/AM (17 mol/L for 9 minutes). 10 See the online-only Supplemental Material for details of indo-1 fluorescence and cell-shortening methods.
The propensity to develop DAD-like arrhythmias was estimated from the number of nonstimulated contractile events (NSE). NSE were defined as spontaneous Ca i T increases with subsequent contractions of myocytes. 11 These spontaneous Ca i T or Ca 2ϩ waves and the associated contraction can be used as a proximal direct index of triggered DAD-like arrhythmias. 12
Confocal Imaging of Intact Cardiac Myocytes
Cells loaded with 10 mol/L Fluo-3 were visualized using a Leica TCS SP5 inverted confocal microscope (Leica, Germany). See the onlineonly Supplemental Material for details of the confocal imaging.
Western Blot
Homogenates, cytosolic fractions, and SR membranes were prepared from the pulverized ventricular tissue from Langendorff-perfused rat hearts, as previously described. 10 See the online-only Supplemental Materials for details.
Adenoviral Gene Transfer and Transfection Efficiency
Dr Roger J. Hajjar (Mount Sinai School of Medicine, New York, NY) kindly supplied 2 first-generation type 5 recombinant adenoviruses that were used: Ad.␤gal, carrying the ␤-galactosidase and the green fluorescent protein genes, and Ad.CaMKII, carrying both the CaMKII␦ C and the green fluorescent protein genes, each under separate cytomegalovirus promoters. For details of the infection of myocytes with the adenovirus, see the online-only Supplemental Material.
In Vivo ECG Measurements
Surface ECG were recorded in BALB/c and SR-AIP mice using standard ECG electrodes for the PowerLab 4ST data acquisition system. Find further details in the online-only Supplemental Material.
Ouabain Doses
The concentration of ouabain used in this study (50 mol/L) has been previously shown to be arrhythmogenic. 13 In the in vivo experiments, 10 mg/kg were injected intraperitoneally. The online-only Supplemental Material details the rationale for using these doses.
Statistical Analysis
The unpaired student t test, Mann-Whitney rank-sum test, Fisher exact test, 1-way ANOVA, or Kruskal-Wallis 1-way ANOVA were used for statistical comparisons when appropriate. Differences were considered significant at PՅ0.05. Parametric and nonparametric continuous data are expressed as meansϮSEM and mediansϮpercentiles, respectively, and categorical data are summarized as percents.
Results
Ouabain Induces Spontaneous Contractile Activity, Ca 2؉ Waves and Activates CaMKII in Rat Myocytes
The effect of 50 mol/L ouabain on cell contraction and the associated intracellular Ca 2ϩ transient (CaiT) was tested in freshly isolated rat myocytes. The propensity for NSE and spontaneous Ca 2ϩ waves was assessed using the protocol depicted in Figure 1A . Myocytes, field stimulated at 0.5 Hz, were perfused with 50 mol/L ouabain. After 20 minutes, stimulation was stopped, and myocyte cell length and CaiT were monitored for an additional 10 minutes in the continuous presence of ouabain. The continuous chart recordings show that ouabain administration produced a typical positive inotropic effect, associated with an increase in CaiT and the presence of a large number of NSE and Ca 2ϩ waves during the nonstimulated period compared with control. Overall, ouabain produced a 60Ϯ5% increase in contractility (nϭ6 myocytes from 4 hearts), associated with a 17Ϯ3% increase in CaiT amplitude (nϭ6 myocytes from 4 hearts), and increased the number of NSE from 11Ϯ4 to 68Ϯ10 events/10 minutes.
We have previously demonstrated that chronic treatment with a low dose of ouabain can activate CaMKII. 8 To evaluate whether CaMKII is also activated by acute ouabain administration, Langendorff-perfused rat hearts were treated for 20 minutes with 50 mol/L ouabain and then freezeclamped for Western blotting. As shown in Figure 1B , ouabain effectively increased CaMKII activity (p-CaMKII). Furthermore, the CaMKII inhibitor, KN93, significantly reduced this activation (nϭ5 hearts). Figure 2 shows typical tracings of cell-shortening of myocytes subjected to the protocol depicted in Figure 1A . As shown earlier, in the presence of ouabain, cells develop a large number of spontaneous contractile events during the nonstimulated period. This ouabain-induced spontaneous activity is largely reduced when cells are pretreated with 2.5 mol/L of the CaMKII inhibitor, KN93. Similar results were obtained in the presence of 1 mol/L of the more specific CaMKII-inhibitory peptide, AIP (ouabainϩAIP). In contrast, the number of NSE was not reduced by the inactive KN93 analog, KN92. Similar results were obtained in experiments performed at 37°C (data not shown). Control experiments showed that the inhibitors used did not significantly affect basal contractility or the number of NSE before the administration of ouabain. The bar graph in Figure 2B shows the overall results of these experiments and additionally indicates that ouabain-induced NSE can be completely prevented by inhibiting SR function with ryanodine and thapsigargin (RyϩTG), indicating a primary role for the SR in ouabain-induced, CaMKII-dependent, spontaneous activity. Interestingly, CaMKII inhibition did not affect the ouabaininduced positive inotropic effect: 168.3Ϯ13.3% of control ouabain (nϭ13 myocytes from 6 hearts) and 159.7Ϯ13.3% of Calcium-calmodulin kinase II (CaMKII) inhibition prevents ouabain-induced spontaneous contractile activity but does not affect its positive inotropic effect. A, Representative continuous chart recordings of cell length show that KN93 does not prevent ouabain inotropy but reduces its spontaneous contractile activity. In contrast, the inactive analog, KN92, did not prevent ouabain-induced nonstimulated contractile events (NSE). Panel B shows average results of these experiments, indicating that the number of ouabain-induced NSE in rat cells were significantly reduced by CaMKII inhibitors KN93 and AIP and by inhibiting sarcoplasmic reticulum (SR) function with ryanodine and thapsigargin but not by KN92. Data are mediansϮpercentiles for 6 to 14 cells from 6 hearts per group (*PϽ0.05, Kruskal-Wallis 1-way ANOVA, Dunn method). control ouabainϩKN93 (nϭ14 myocytes from 6 hearts). To further confirm the central role played by CaMKII in ouabaininduced spontaneous activity by nonpharmacologic means, 2 different strategies were followed: (1) we overexpressed CaMKII␦c (Ad.CaMKII) in cultured rat myocytes by adenoviral gene transfer, and (2) we employed transgenic mouse myocytes expressing SR-targeted CaMKII inhibitor AIP (SR-AIP). Figure  3A shows that 24 hours after infection, rat myocytes retained their rod shape morphology and functional integrity and presented (nearly 100%) a robust expression of the reporter gene, green fluorescent protein, indicating that our gene of interest was also overexpressed. At this time, CaMKII expression was significantly increased, as confirmed by Western blotting ( Figure 3B ). Functional experiments were then carried out to examine the susceptibility of these cells to develop ouabain-induced NSE in comparison with cells infected in similar conditions but with the adenovirus carrying the ␤-galactosidase gene (Ad.␤gal). The repre-sentative tracings depicted in Figure 3C show that there were no significant differences between infected groups in the basal contraction and the NSE. Of note, spontaneous contractile activity in the absence of ouabain was lower than the one observed in fresh cells. The reason for this is not apparent to us but could be because of the prolonged culture period. As in fresh cells, ouabain increased spontaneous activity in both ␤-galactosidase and CaMKII overexpressing cells; however, the incidence of spontaneous contractile activity was significantly higher in Adv.CaMKII cells. In contrast, CaMKII overexpression did not affect the ouabain-induced positive inotropic effect. The bar graphs in Figure 3C show the overall results of these experiments. These data serve to confirm that CaMKII is functionally linked with ouabain-induced NSE and arrhythmogenesis but not with inotropy.
Consistently, myocytes isolated from WT mice show a similar increase in the number of NSE in response to ouabain as rat cells; however, ouabain failed to increase the incidence of spontaneous contractile activity in SR-AIP mice myocytes ( Figure 4A ). Overall results show that ouabain significantly increases the number of NSE in WT controls and that these events evoked by ouabain do not significantly increase in SR-AIP cells ( Figure 4B ). Figure 4C shows that ouabain produced a similar positive inotropic effect in myocytes isolated from WT or SR-AIP mice.
Mechanisms Underlying CaMKII-Mediated Ouabain-Induced Arrhythmias
Ca 2ϩ waves generate spontaneous contractions, but, more importantly, they are also the substrate for DAD-triggered arrhythmias, which are thought to be responsible for digitalis intoxication. 14, 15 At least 2 factors have been shown to underlie spontaneous SR Ca 2ϩ release or Ca 2ϩ waves: (1) an increase in SR Ca 2ϩ load and (2) an increase in the sensitivity of the RyR for Ca 2ϩ release. 7, 15 CaMKII has been shown to enhance both these processes, 16, 17 suggesting its potential involvement in cardiotonic steroid (CTS)-induced arrhythmias; however, whether CaMKII favors ouabain-induced arrhythmogenicity by affecting SR Ca 2ϩ load, the sensitivity of the RyR for Ca 2ϩ release, or both these mechanisms, is unknown. Figure 5A shows the effect of ouabain on the phosphorylation of the CaMKII-dependent PLN residue, Thr17. Ouabain significantly increased Thr17 phosphorylation, and this effect was prevented by 2.5 mol/L KN93. The traces in Figure 5B show the effect of ouabain in the absence and presence of KN93 on caffeine-induced Ca 2ϩ transients, performed to evaluate SR Ca 2ϩ content. As previously reported by us and others, 8, 15 ouabain significantly increases SR Ca 2ϩ content; however, KN93 failed to affect caffeine-induced SR Ca 2ϩ release. On average, SR Ca 2ϩ load increased by 25Ϯ5% in the presence of ouabain (nϭ6 from 3 hearts) and by 24Ϯ6% in the presence of ouabain ϩ2.5 mol/L KN93 (nϭ8 from 4 hearts). These results suggest that although ouabain enhances PLN phosphorylation, which would increase SERCA2a activity and favor SR Ca 2ϩ load, this mechanism is not required for the observed increase in SR Ca 2ϩ content produced by ouabain challenge. To further assess whether ouabaininduced CaMKII-dependent PLN phosphorylation is involved in the generation of spontaneous contractile activity, and therefore in Ca 2ϩ waves and DADs, we used PLN double-mutant (PLN-DM) mouse myocytes. Figure 5C shows overall results, indicating that ouabain significantly and similarly increased the number of NSE in both WT and PLN-DM myocytes, suggesting that targets other than PLN are involved in ouabain-induced, CaMKII-dependent spontaneous activity. Figure 6A shows that ouabain significantly increased the phosphorylation of the CaMKII-dependent RyR residue, Ser2814, and that this effect was prevented by 2.5 mol/L KN93. RyR phosphorylation can increase the sensitivity of the channel for Ca 2ϩ release, promoting diastolic SR Ca 2ϩ leak and Ca 2ϩ waves. 16 Using confocal imaging, we assessed Ca 2ϩ spark frequency under resting conditions, which reflects Ca 2ϩ leak from the SR. 18 After 20 minutes of pacing rat myocytes at 0.5 Hz in the presence of ouabain, pacing was stopped, and Ca 2ϩ sparks were measured during 60 s. Figure  6B shows representative fluorescence images and overall results demonstrating that ouabain increases spark frequency. Additionally, we quantified the occurrence of spontaneous Ca 2ϩ waves. Whereas in the absence of ouabain, myocytes hardly showed Ca 2ϩ waves, ouabain treatment significantly enhanced the number of spontaneous Ca 2ϩ waves from 0.03Ϯ0.02 to 0.10Ϯ0.01 waves* s Ϫ1 (nϭ8 cells from 4 hearts). KN93 prevented both the ouabain-induced increase in Ca 2ϩ spark frequency and in Ca 2ϩ wave occurrence, indicating that CaMKII underlies these events.
Effect of CaMKII Inhibition on Ouabain-Induced Increase in SR Ca 2؉ Load
Effect of CaMKII on RyR Phosphorylation, SR Ca 2؉ Leak, and Spontaneous Ca 2؉ Waves
CaMKII Inhibition Prevents Ouabain-Induced Arrhythmias In Vivo
In the absence of ouabain, WT mice did not exhibit spontaneous arrhythmias as evidenced from continuous in vivo ECG measurements. As shown in Figure 7A , 10 mg/kg IP administration of ouabain induced a variety of ECG alterations in a background of sinus bradycardia and atrioventricular block because of the vagal effects of ouabain. Among these alterations, ventricular ectopic beats and sustained ventricular tachycardia were the most common. These arrhythmic events were diminished in the presence of KN93 (30 mol/kg IP; nϭ9; Figure 7B ) and absent in SR-AIP mice (nϭ5; Figure 7C ). Table shows the incidence of ventricular ectopic beats and sustained ventricular tachycardia in the presence of ouabain alone, ouabainϩKN93, or SR-AIP mice treated with ouabain. In addition, KN93 significantly reduced ouabain-induced mice mortality. Nine out of 11 (18% survival) mice treated with ouabain died after treatment, whereas 6 out of 9 (67% survival) mice pretreated with KN93 (Pϭ0.04 vs ouabain) and 4 out of 5 SR-AIP (80% survival) mice (Pϭ0.03 vs ouabain) survived ouabain treatment.
CaMKII Inhibition Prevents Digoxin-Induced Spontaneous Activity
To examine whether the observed effect of ouabain on spontaneous activity was common to other related cardiotonic steroids, we studied the effect of digoxin (DIG) on the number of NSE, SR Ca 2ϩ load, and Ca 2ϩ spark and wave frequency in the absence and presence of KN93. Figure 8 shows that a low, nontoxic but inotropic dose of DIG (10 mol/L) 19 does not increase the number of NSE nor the frequency of spontaneous Ca 2ϩ waves. This dose of DIG showed a tendency to increase SR Ca 2ϩ load and spark frequency; however, these increases did not attain significant levels. In contrast, 75 mol/L DIG significantly increased the number of NSE and SR Ca 2ϩ load as well as Ca 2ϩ spark and wave frequency. Similar to the results obtained with ouabain, CaMKII inhibition with KN93 did not prevent the DIG- induced increase in SR Ca 2ϩ load but reduced the number of NSE, as well as Ca 2ϩ spark and wave frequency.
Discussion
Steroidal glycosides extracted from the leaves of plants from the genus Digitalis have been used for the treatment of congestive heart failure for more than 200 years; however, these compounds have a narrow therapeutic window because of the presence of adverse toxic effects, characterized primarily by arrhythmias and, as recently shown by us and others, by apoptosis, 2,8 which limit their extensive use in the clinical practice. Digitalis-induced arrhythmogenic effects are, as yet, not completely understood. It has been suggested that NCXmediated Ca 2ϩ influx, resulting in SR Ca 2ϩ overload, 15 could increase RyR open probability and lead to spontaneous diastolic SR Ca 2ϩ release that could activate a transient I ti , responsible for the generation of DADs, spontaneous action potentials, and ventricular arrhythmias. A digitalis-induced increase in Ca 2ϩ i could also activate CaMKII, which has been shown not only to favor SR Ca 2ϩ load but also to increase the Ca 2ϩ sensitivity of the RyR and to induce arrhythmias. 9, 16 Thus, we hypothesized that CaMKII could be involved in glycoside-induced arrhythmogenesis. In the present study, we show that ouabain activates CaMKII, and, for the first time, we demonstrate that ouabain-induced arrhythmias are CaMKII-dependent. Furthermore, we show that ouabain promotes CaMKII-dependent arrhythmogenesis both in vitro and in vivo, and we demonstrate that CaMKII inhibition prevents ouabain-induced arrhythmias without affecting its positive inotropic effect, suggesting a potential therapeutic benefit for CaMKII inhibition during glycoside treatment. Finally, our results indicate that CaMKII-mediated phosphorylation of the RyR, resulting in Ca 2ϩ leak from the SR and enhanced Ca 2ϩ wave formation, would be the underlying mechanism involved. Highlighting the clinical relevance of our findings, it is noteworthy that we obtained similar results using digoxin, a structurally different cardiotonic steroid routinely used in the clinical practice. Figure 6 . Effect of ouabain on ryanodine receptor (RyR) phosphorylation, Ca 2ϩ spark and wave frequency. A, Representative blots and overall results show that ouabain increases RyR Ser2814 phosphorylation and that KN93 prevents this increase. Data are expressed as meansϮSEM from 5 independent experiments from 5 hearts (*PϽ0.05, 1-way ANOVA, Newman-Keuls) B, Original confocal line-scan images of myocytes in the absence of ouabain or either in the presence of ouabain alone or ouabainϩKN93. The bar graphs on the right indicate that ouabain significantly increased Ca 2ϩ spark frequency and Ca 2ϩ wave occurrence and that these effects were inhibited by KN93. Data are mediansϮpercentiles for 6 to 8 cells from 3 hearts per group (*PϽ0.05, Kruskal-Wallis 1-way ANOVA, Dunn method).
Ouabain Toxicity and CaMKII
It is now generally accepted that ouabain increases intracellular Na ϩ through the inhibition of Na ϩ /K ϩ -ATPase. The resulting reduction of the transarcolemmal Na ϩ gradient favors the reverse mode of the NCX, which increases intracellular Ca 2ϩ load and results in a positive inotropic effect. It has been proposed that when this Ca 2ϩ load exceeds the capacity of the SR, abnormal Ca 2ϩ release occurs, which, in turn, triggers abnormal electric activity and arrhythmic contractions. In the present study, we observed that ouabain increased the activity of CaMKII (p-CaMKII) and that ouabain-induced arrhythmic contractions were significantly reduced by the CaMKII inhibitor KN93 (Figures 1 and 2) .
These results indicate that CaMKII is involved in ouabaininduced arrhythmogenesis. Further confirming the participation of CaMKII, we showed that (1) KN92, the inactive analog of KN93, failed to affect ouabain-induced NSE; (2) AIP, a structurally different inhibitor of CaMKII, also prevented ouabain-induced NSE; (3) CaMKII overexpression exacerbated ouabain-induced NSE; (4) transgenic mice expressing SR-targeted CaMKII inhibition (SR-AIP) were protected from the toxic effects of ouabain; and (5) in vivo, ouabain failed to induce arrhythmias and death in WT mice pretreated with KN93 and in SR-AIP mice. These findings (combining pharmacological inhibition, genetic manipulation, and in vivo studies) provide substantial evidence indicating that CaMKII is mechanistically involved in ouabaininduced spontaneous activity and arrhythmogenesis.
Mechanisms Underlying Ouabain-Induced CaMKII-Dependent Arrhythmias
Cardiotonic steroid-induced arrhythmias have been shown to be mediated by Ca 2ϩ waves, resulting in DADs, which generate spontaneous action potentials. 3, 6 A potential role for CaMKII in DADs formation has been previously reported. 12, 20, 21 Wu and colleagues were the first to describe that CaMKII triggers an NCX-dependent arrhythmogenic transient I ti through its effect of SR Ca 2ϩ load/release. 20 Said Overall data shows the incidence of ventricular ectopic beats (premature or escape beats) and sustained ventricular tachycardia in BALB/c mice in the absence and presence of calcium-calmodulin kinase II inhibition (KN93 and SR-AIP mice). Sustained ventricular tachycardia (VT) was defined as a run of Ͼ10 ventricular ectopic beats.
WT indicates wild type; SR, sarcoplasmic reticulum. and colleagues showed that post acidosis-induced DADtriggered arrhythmias could be prevented by CaMKII inhibition and concluded that CaMKII would enhance SERCA2a activity by phosphorylating phospholamban at its Thr17 site, thus increasing SR Ca 2ϩ load and favoring DAD formation. 21 Using a protocol similar to the one used in the present study, Curran and colleagues also implicated CaMKII in DADtriggered arrhythmias of the failing heart. 12 In this case, the authors concluded that CaMKII increases the sensitivity of the RyR, lowering the threshold for spontaneous Ca 2ϩ release and thus providing the arrhythmogenic substrate. These studies clearly define the 2 main factors responsible for increasing the propensity for Ca 2ϩ waves and subsequent DADs increased SR Ca 2ϩ load, and/or increased Ca 2ϩ sensitivity of the RyR. We showed that ouabain increased both SR Ca 2ϩ load ( Figure 5 ) and the phosphorylation of the RyR associated with SR Ca 2ϩ leak ( Figure 6 ), indicative of increased Ca 2ϩ sensitivity of the RyR; however, CaMKII inhibition, which prevented ouabain-induced arrhythmias, did not affect SR Ca 2ϩ load, whereas it reduced RyR phosphor-ylation, Ca 2ϩ leak, and Ca 2ϩ wave propensity ( Figure 6 ). Similar to the conclusion of Curran and colleagues, these results suggest that CaMKII would primarily mediate ouabain-induced arrhythmias through increasing the sensitivity of the RyR to Ca 2ϩ . Our results showing that the ouabain-induced increase in PLN Thr17 phosphorylation could be prevented with KN93 seems to be at odds with the failure of KN93 to reduce SR Ca 2ϩ load, given that this phosphorylation is known to enhance SERCA2a activity and SR Ca 2ϩ uptake; however, in the rat, a species with high resting SR Ca 2ϩ , 22 ouabain can fully load the SR through Ca 2ϩ influx via the NXC, and, therefore, CaMKII-dependent PLN phosphorylation would not further increase SR Ca 2ϩ load. Our results showing that ouabain-induced spontaneous contractile activity was similar between PLN-DM myocytes and WT myocytes ( Figure 5 ) would support the contention that CaMKII-dependent PLN phosphorylation is not involved in ouabain-induced arrhythmias; however, another possible interpretation of our results is that Thr17 phosphorylation of PLN does play a role in the arrhythmic pattern described, maintaining the increased SR Ca 2ϩ load produced by ouabain, just matching the SR Ca 2ϩ leak produced by RyR phosphorylation. If this were the case, one could further speculate that PLN-DM mice might compensate for the lack of PLN phosphorylation by the increase in L-type Ca 2ϩ channels, typical of these mice. 23 In any case, our results showing that KN93 completely prevents ouabain-induced arrhythmias, without affecting SR Ca 2ϩ load, while preventing RyR phosphorylation, SR Ca 2ϩ leak, and Ca 2ϩ wave propensity, would suggest that increased SR Ca 2ϩ load alone is not sufficient to promote ouabain-induced arrhythmias. Interestingly, the inverse conclusion seems to be also true, as suggested by Eisner and colleagues, who elegantly showed that increasing RyR receptor open probability alone is not enough to produce arrhythmogenic diastolic Ca 2ϩ release and that a parallel increase in SR Ca 2ϩ load is required. 14 In the case of ouabain, the NCX would provide Ca 2ϩ to load the SR and activate CaMKII, which, in addition to other targets, would phosphorylate the RyR and increase its Ca 2ϩ sensitivity, lowering the threshold for spontaneous Ca 2ϩ release. Thus, the NCX would couple the arrhythmogenic RyR phosphorylation with SR Ca 2ϩ overload that mediate the spontaneous Ca 2ϩ waves, DADs, and eventually arrhythmias. Indeed, several studies have pointed out the critical role of the NCX in digitalis-induced arrhythmias. 24, 25 In a recent report, ouabain-triggered arrhythmias were associated with mitochondrial dysfunction. 26 This study convincingly showed that ouabain-induced arrhythmias could be prevented by blocking the mitochondrial NCX. These results, obtained using a different species and by inducing arrhythmias with ouabain plus isoproterenol, make direct comparisons to our results difficult; however, one explanation that could reconcile the apparent discrepancies with our results is that, in the context of ouabain challenge, mitochondrial NCX activation could provide an additional source of Ca 2ϩ for loading the SR and for CaMKII activation, thus its blockade would reduce these processes and prevent arrhythmogenesis.
Consistent with our findings, several studies have demonstrated that catecholaminergic polymorphic ventricular tachycardia (an arrhythmic condition which resembles that of digitalis-toxicity) is also linked to Ca 2ϩ leak from the SR and can be triggered by ouabain. 6 More importantly, catecholaminergic polymorphic ventricular tachycardia can be prevented by CaMKII inhibition. 27 These results not only demonstrate the fundamental role of CaMKII in these types of arrhythmias but also highlight the potential use of CaMKII inhibition as a valid therapeutic option for both catecholaminergic polymorphic ventricular tachycardia and digitalisinduced arrhythmias.
In summary, we have presented evidence indicating that cardiotonic steroids activate CaMKII, which increases the Ca 2ϩ sensitivity of the RyR, lowering the threshold for spontaneous release and predisposing the heart for DADtriggered arrhythmias. These results highlight the need for a redefinition of the mechanisms underlying digitalis-induced arrhythmias in general, attributed almost exclusively to an increase in SR Ca 2ϩ load. These findings could help to explain the enhanced propensity for fatal arrhythmias observed in heart failure patients, where high levels of endog-enous ouabain-like compounds 28 and CaMKII expression 29 have been reported. Finally, although the benefit of glycoside therapy in patients with endstage heart failure is widely acknowledged, the finding that CaMKII inhibition prevents ouabain-induced arrhythmias, without affecting its positive inotropic effect, suggests the potential use of CaMKII inhibitors as an adjunct to digitalis treatment for cardiovascular disease.
